https://www.prnewswire.com/news-releases/tengion-announces-fda-orphan-drug-designation-for-neo-urinary-conduit-123560739.html
Tengion Announces FDA Orphan-Drug Designation for Neo-Urinary Conduit
/PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to the...
orphan drug designationannouncesfdaneourinary